Ruppert, Mihály
Korkmaz-Icöz, Sevil
Benczik, Bettina
Ágg, Bence
Nagy, Dávid
Bálint, Tímea
Sayour, Alex Ali
Oláh, Attila
Barta, Bálint András
Benke, Kálmán
Ferdinandy, Péter
Karck, Matthias
Merkely, Béla
Radovits, Tamás
Szabó, Gábor
Funding for this research was provided by:
European Union (RRF-2.3.1-21-2022-00003)
Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund (TKP2021-EGA-23)
Hungarian Academy of Sciences (János Bolyai Research Scholarship)
National Research, Development and Innovation Office (NKFIH) of Hungary (K134939)
Ministry for Innovation and Technology from the National Research, Development and Innovation Fund source (ÚNKP-20-4-I-SE-7, ÚNKP-21-4-II-SE-18)
National Research, Development and Innovation Office of Hungary (NVKP-16-1-2016- 0017)
Semmelweis University
Article History
Received: 6 February 2023
Accepted: 20 September 2023
First Online: 26 September 2023
Competing interests
: P.F. is the founder and CEO of, and B.Á. is employed by Pharmahungary Group, a group of R&D companies and the provider of miRNAtarget.com. All the other authors have nothing to declare.